86 related articles for article (PubMed ID: 11281956)
1. Dopamine receptor D3 gene and response to lithium prophylaxis in mood disorders.
Serretti A; Lilli R; Lorenzi C; Franchini L; Smeraldi E
Int J Neuropsychopharmacol; 1998 Dec; 1(2):125-129. PubMed ID: 11281956
[TBL] [Abstract][Full Text] [Related]
2. Tryptophan hydroxylase gene and response to lithium prophylaxis in mood disorders.
Serretti A; Lilli R; Lorenzi C; Gasperini M; Smeraldi E
J Psychiatr Res; 1999; 33(5):371-7. PubMed ID: 10504005
[TBL] [Abstract][Full Text] [Related]
3. Dopamine receptor D2 and D4 genes, GABA(A) alpha-1 subunit genes and response to lithium prophylaxis in mood disorders.
Serretti A; Lilli R; Lorenzi C; Franchini L; Di Bella D; Catalano M; Smeraldi E
Psychiatry Res; 1999 Jul; 87(1):7-19. PubMed ID: 10512150
[TBL] [Abstract][Full Text] [Related]
4. Serotonin transporter gene associated with lithium prophylaxis in mood disorders.
Serretti A; Lilli R; Mandelli L; Lorenzi C; Smeraldi E
Pharmacogenomics J; 2001; 1(1):71-7. PubMed ID: 11913731
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics of lithium prophylaxis in mood disorders: analysis of COMT, MAO-A, and Gbeta3 variants.
Serretti A; Lorenzi C; Lilli R; Mandelli L; Pirovano A; Smeraldi E
Am J Med Genet; 2002 May; 114(4):370-9. PubMed ID: 11992559
[TBL] [Abstract][Full Text] [Related]
6. Serotonin receptor 2A, 2C, 1A genes and response to lithium prophylaxis in mood disorders.
Serretti A; Lorenzi C; Lilli R; Smeraldi E
J Psychiatr Res; 2000; 34(2):89-98. PubMed ID: 10758249
[TBL] [Abstract][Full Text] [Related]
7. Further evidence for a possible association between serotonin transporter gene and lithium prophylaxis in mood disorders.
Serretti A; Malitas PN; Mandelli L; Lorenzi C; Ploia C; Alevizos B; Nikolaou C; Boufidou F; Christodoulou GN; Smeraldi E
Pharmacogenomics J; 2004; 4(4):267-73. PubMed ID: 15111989
[TBL] [Abstract][Full Text] [Related]
8. Dopamine receptor D2 and D3 gene variants are not associated with the antidepressant effect of total sleep deprivation in bipolar depression.
Benedetti F; Serretti A; Colombo C; Lilli R; Lorenzi C; Smeraldi E
Psychiatry Res; 2003 Jun; 118(3):241-7. PubMed ID: 12834818
[TBL] [Abstract][Full Text] [Related]
9. Dopamine D3 receptor gene not associated with symptomatology of major psychoses.
Serretti A; Lattuada E; Cusin C; Lilli R; Lorenzi C; Smeraldi E
Am J Med Genet; 1999 Oct; 88(5):476-80. PubMed ID: 10490702
[TBL] [Abstract][Full Text] [Related]
10. [Predictors of prophylactic response to lithium].
Rohayem J; Baylé JF; Richa S
Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
[TBL] [Abstract][Full Text] [Related]
11. Prophylaxis of schizoaffective disorder with lithium or carbamazepine: outcome after long-term follow-up.
Baethge C; Gruschka P; Berghöfer A; Bauer M; Müller-Oerlinghausen B; Bschor T; Smolka MN
J Affect Disord; 2004 Apr; 79(1-3):43-50. PubMed ID: 15023479
[TBL] [Abstract][Full Text] [Related]
12. Clinical and pathogenic aspects of candidate genes for lithium prophylactic efficacy.
Rybakowski JK; Czerski P; Dmitrzak-Weglarz M; Kliwicki S; Leszczynska-Rodziewicz A; Permoda-Osip A; Skibinska M; Suwalska A; Szczepankiewicz A; Hauser J
J Psychopharmacol; 2012 Mar; 26(3):368-73. PubMed ID: 21890592
[TBL] [Abstract][Full Text] [Related]
13. Classifying mood disorders by age-at-onset instead of polarity.
Benazzi F
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):86-93. PubMed ID: 18992784
[TBL] [Abstract][Full Text] [Related]
14. Decreased levels of dopamine D3 receptor mRNA in schizophrenic and bipolar patients.
Vogel M; Pfeifer S; Schaub RT; Grabe HJ; Barnow S; Freyberger HJ; Cascorbi I
Neuropsychobiology; 2004; 50(4):305-10. PubMed ID: 15539862
[TBL] [Abstract][Full Text] [Related]
15. Polymorphism of circadian clock genes and prophylactic lithium response.
Rybakowski JK; Dmitrzak-Weglar M; Kliwicki S; Hauser J
Bipolar Disord; 2014 Mar; 16(2):151-8. PubMed ID: 24636202
[TBL] [Abstract][Full Text] [Related]
16. Effects of the dopamine D3 receptor (DRD3) gene polymorphisms on risperidone response: a pharmacogenetic study.
Xuan J; Zhao X; He G; Yu L; Wang L; Tang W; Li X; Gu N; Feng G; Xing Q; He L
Neuropsychopharmacology; 2008 Jan; 33(2):305-11. PubMed ID: 17429404
[TBL] [Abstract][Full Text] [Related]
17. Interaction of the DRD3 and BDNF gene variants in subtyped bipolar disorder.
Lee SY; Chen SL; Chen SH; Chu CH; Chang YH; Lin SH; Huang SY; Tzeng NS; Kuo PH; Lee IH; Yeh TL; Yang YK; Lu RB
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):382-7. PubMed ID: 22877924
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic lithium response and polymorphism of the brain-derived neurotrophic factor gene.
Rybakowski JK; Suwalska A; Skibinska M; Szczepankiewicz A; Leszczynska-Rodziewicz A; Permoda A; Czerski PM; Hauser J
Pharmacopsychiatry; 2005 Jul; 38(4):166-70. PubMed ID: 16025419
[TBL] [Abstract][Full Text] [Related]
19. Lithium in the long-term treatment of bipolar disorders.
Kleindienst N; Greil W
Eur Arch Psychiatry Clin Neurosci; 2003 Jun; 253(3):120-5. PubMed ID: 12904975
[TBL] [Abstract][Full Text] [Related]
20. Catechol-O-methyltransferase gene variants in mood disorders in the Italian population.
Serretti A; Rotondo A; Lorenzi C; Smeraldi E; Cassano GB
Psychiatr Genet; 2006 Oct; 16(5):181-2. PubMed ID: 16969269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
